Stringent cessation criterion results in better durability of lamivudine treatment: a prospective clinical study in hepatitis B e antigen-positive chronic hepatitis B patients.

Source:http://linkedlifedata.com/resource/pubmed/id/19758278

Download in:

View as

General Info

PMID
19758278